期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

改善急性ST段抬高型心肌梗死的生存链 被引量：7

暂未订购
导出
摘要 急性ST段抬高型心肌梗死的生存链近来受到关注,本文就缩短从患者发生症状至医院就诊以及从患者到达医院至球囊扩张(PCI治疗)两个时间段的文献报道作一综述,希望能推动我国急性ST段抬高型心肌梗死的治疗。
作者 沈卫峰 沈迎 张奇
机构地区 上海交通大学医学院附属瑞金医院心脏科
出处 《国际心血管病杂志》 2007年第6期391-394,共4页 International Journal of Cardiovascular Disease
基金 上海市科委重大项目(05DZ19503)
关键词 生存链 再灌注治疗 急性心肌梗死
分类号 R542.22 [医药卫生—心血管疾病]
  • 相关文献

参考文献20

  • 1[1]Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary.A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction)[J].J Am Coll Cardiol,2004,44(3):671-719.
  • 2[2]Silber S,Albertsson P,Aviles FF,et al.Guidelines for percutaneous coronary interventions.The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology[J].Eur Heart J,2005,26(8):804-847.
  • 3[3]Ornato JP.The ST-segment-elevation myocardial infarction chain of survival[J].Circulation,2007,116 (1):6-9.
  • 4[4]Van de Werf F,Ardissino D,Betriu A,et al.Management of acute myocardial infarction in patients presenting with ST-segment elevation.The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology[J].Eur Heart J,2003,24(1):28-66.
  • 5[5]Bassand JP,Danchin N,Filippatos G,et al.Implementation of reperfusion therapy in acute myocardial infarction.A policy statement from the European Society of Cardiology[J].Eur Heart J,2005,26(24):2733-2741.
  • 6[6]McNamara RL,Wang YF,Herrin J,et al.Effect of doorto-balloon time on mortality in patients with ST-segment elevation myocardial infarction[J].J Am Coll Cardiol,2006,47(11):2180-2186.
  • 7[7]Mensah GA,Hand MM,Antman EM,et al.Development of systems of care for ST-elevation myocardial infarction patients:the patient and public perspective[J].Circulation,2007,116(2):e33-e38.
  • 8[8]Henry TD,Sharkey SW,Burke MN,et al.A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction[J].Circulation,2007,116(7):721-728.
  • 9[9]Ting HH,Rihal CS,Gersh BJ,et al.Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction:the Mayo Clinic STEMI Protocol[J].Circulation,2007,116(7):729-736.
  • 10[10]Jacobs AK,Antman EM,Faxon DP,et al.Development of systems of care for ST-elevation myocardial infarction patients:executive summary[J].Circulation,2007,116(2):217-230.

二级参考文献19

  • 1[1]Elmouchi DA,Bates ER.Platelet glycoprotein Ⅱb/Ⅲa inhibitor therapy in non-ST segment elevation acute coronary syndromes[J].Minerva Cardioangiol,2003,51 (5):547-560.
  • 2[2]Valgimigli M,Percoco G,Malagutti P,et al.Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction:a randomized trial[J].JAMA,2005,293 (17):2109-2117.
  • 3[3]Heitzer,T Ollmann,I Koke,K et al.Platelet Glycoprotein Ⅱb/Ⅲa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease[J].Circulation,2003,108 (5):536-541.
  • 4[4]Warnholtz A,Ostad MA,Heitzer T,et al.Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease[J].Am J Cardiol,2005,95 (1):20-23
  • 5[5]De Luca G,Smit JJ,Ernst N,et al.Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction[J].Thromb Haemost,2005,93 (5):820-823.
  • 6[6]Martinez-Rios MA,Rosas M,Gonzalez H,et al.Comparison of reperfusion regimens with or without tirofiban in STelevation acute myocardial infarction[J].Am J Cardiol,2004,93 (3):280-287.
  • 7[7]Lavi S,Gruberg L,Kapeliovich M,et al.The impact of GP Ⅱb/Ⅲa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients[J].J Invasive Cardiol,2005,17 (6):296-299.
  • 8[8]Roffi M,Chew DP,Mukherjee D,et al.Platelet glycoprotein Ⅱb/Ⅲa inhibition in acute coronary syndromes.Gradient of benefit related to the revascularization strategy[J].Eur Heart J,2002,23 (18):1441-1448.
  • 9[9]Sabatine MS,Morrow DA,Giugliano RP,et al.Implications of upstream glycoprotein Ⅱb/Ⅲa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction:a comparison of the Thrombolysis In Myocardial Infarction (TIMI) ⅢB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial[J].Circulation,2004,109 (7):874-880.
  • 10[10]Marsh JD.Early use of glycoprotein Ⅱb/Ⅲa-receptor inhibitors in non-ST-segment-elevation acute coronary syndromes[J].Am J Health Syst Pharm,2002,59 (21 Suppl 7):S15-S26.

共引文献71

同被引文献37

引证文献7

二级引证文献16

国际心血管病杂志
2007年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部